224
Durzynska J, Przysiecka L, Nawrot R, Barylski J, Nowicki G, Warowicka A et al (2015) Viral and
other cell-penetrating peptides as vectors of therapeutic agents in medicine. J Pharmacol Exp
Ther 354(1):32–42. https://doi.org/10.1124/jpet.115.223305
Fair RJ, Tor Y (2014) Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem
6:25–64. https://doi.org/10.4137/PMC.S14459
Fensterseifer ICM, Felicio MR, Alves ESF, Cardoso MH, Torres MDT, Matos CO et al (2019)
Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative
bacteria. Biochim Biophys Acta Biomembr 1861(7):1375–1387. https://doi.org/10.1016/j.
bbamem.2019.03.016
Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol
13(10):491–496. https://doi.org/10.1016/j.tim.2005.08.007
Fishman N (2006). Antimicrobial stewardship. Am J Med 119(6 Suppl 1):S53–S61; discussion
S62-70. https://doi.org/10.1016/j.amjmed.2006.04.003
Garau J, Nicolau DP, Wullt B, Bassetti M (2014) Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance. J
Glob Antimicrob Resist 2(4):245–253. https://doi.org/10.1016/j.jgar.2014.08.002
Geary RS (2009) Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin Drug
Metab Toxicol 5(4):381–391. https://doi.org/10.1517/17425250902877680
Gleave ME, Monia BP (2005) Antisense therapy for cancer. Nat Rev Cancer 5(6):468–479. https://
doi.org/10.1038/nrc1631
Goodridge LD (2010) Designing phage therapeutics. Curr Pharm Biotechnol 11(1):15–27
Hayes JD, Wolf CR (1990) Molecular mechanisms of drug resistance. Biochem J 272(2):281–295.
https://doi.org/10.1042/bj2720281
Hollister EB, Gao C, Versalovic J (2014) Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 146(6):1449–1458.
https://doi.org/10.1053/j.gastro.2014.01.052
Jonczyk-Matysiak E, Lodej N, Kula D, Owczarek B, Orwat F, Miedzybrodzki R et al (2019)
Factors determining phage stability/activity: challenges in practical phage application. Expert
Rev Anti-Infect Ther 17:1–24. https://doi.org/10.1080/14787210.2019.1646126
Kaloudas D, Pavlova N, Penchovsky R (2018) EBWS: Essential bioinformatics Web services
for sequence analyses. IEEE/ACM transactions on computational biology and bioinformatics
16(3):942–953. https://doi.org/10.1109/TCBB.2018.2816645
Kauffman WB, Fuselier T, He J, Wimley WC (2015) Mechanism matters: a taxonomy of cell
penetrating peptides. Trends Biochem Sci 40(12):749–764. https://doi.org/10.1016/j.
tibs.2015.10.004
Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ (2010) Changes in the composition of the human
fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.
J Clin Gastroenterol 44(5):354–360. https://doi.org/10.1097/MCG.0b013e3181c87e02
Kolb SJ, Kissel JT (2011) Spinal muscular atrophy: a timely review. Arch Neurol 68(8):979–984.
https://doi.org/10.1001/archneurol.2011.74
Kolb SJ, Kissel JT (2015) Spinal muscular atrophy. Neurol Clin 33(4):831–846. https://doi.
org/10.1016/j.ncl.2015.07.004
Kurreck J (2003) Antisense technologies. Improvement through novel chemical modifications. Eur
J Biochem 270(8):1628–1644. https://doi.org/10.1046/j.1432-1033.2003.03555.x
Langdon A, Crook N, Dantas G (2016) The effects of antibiotics on the microbiome throughout
development and alternative approaches for therapeutic modulation. Genome Med 8(1):39.
https://doi.org/10.1186/s13073-016-0294-z
Langel U (2019) Classes and applications of cell-penetrating peptides. In: CPP, cell-penetrating
peptides. Springer, Singapore, pp 61–63
Le CF, Fang CM, Sekaran SD (2017) Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother 61(4). https://doi.org/10.1128/AAC.02340-16
Lehman SM, Donlan RM (2015) Bacteriophage-mediated control of a two-species biofilm formed
by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary
A. Valsamatzi-Panagiotou et al.
Durzynska J, Przysiecka L, Nawrot R, Barylski J, Nowicki G, Warowicka A et al (2015) Viral and
other cell-penetrating peptides as vectors of therapeutic agents in medicine. J Pharmacol Exp
Ther 354(1):32–42. https://doi.org/10.1124/jpet.115.223305
Fair RJ, Tor Y (2014) Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem
6:25–64. https://doi.org/10.4137/PMC.S14459
Fensterseifer ICM, Felicio MR, Alves ESF, Cardoso MH, Torres MDT, Matos CO et al (2019)
Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative
bacteria. Biochim Biophys Acta Biomembr 1861(7):1375–1387. https://doi.org/10.1016/j.
bbamem.2019.03.016
Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol
13(10):491–496. https://doi.org/10.1016/j.tim.2005.08.007
Fishman N (2006). Antimicrobial stewardship. Am J Med 119(6 Suppl 1):S53–S61; discussion
S62-70. https://doi.org/10.1016/j.amjmed.2006.04.003
Garau J, Nicolau DP, Wullt B, Bassetti M (2014) Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance. J
Glob Antimicrob Resist 2(4):245–253. https://doi.org/10.1016/j.jgar.2014.08.002
Geary RS (2009) Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin Drug
Metab Toxicol 5(4):381–391. https://doi.org/10.1517/17425250902877680
Gleave ME, Monia BP (2005) Antisense therapy for cancer. Nat Rev Cancer 5(6):468–479. https://
doi.org/10.1038/nrc1631
Goodridge LD (2010) Designing phage therapeutics. Curr Pharm Biotechnol 11(1):15–27
Hayes JD, Wolf CR (1990) Molecular mechanisms of drug resistance. Biochem J 272(2):281–295.
https://doi.org/10.1042/bj2720281
Hollister EB, Gao C, Versalovic J (2014) Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 146(6):1449–1458.
https://doi.org/10.1053/j.gastro.2014.01.052
Jonczyk-Matysiak E, Lodej N, Kula D, Owczarek B, Orwat F, Miedzybrodzki R et al (2019)
Factors determining phage stability/activity: challenges in practical phage application. Expert
Rev Anti-Infect Ther 17:1–24. https://doi.org/10.1080/14787210.2019.1646126
Kaloudas D, Pavlova N, Penchovsky R (2018) EBWS: Essential bioinformatics Web services
for sequence analyses. IEEE/ACM transactions on computational biology and bioinformatics
16(3):942–953. https://doi.org/10.1109/TCBB.2018.2816645
Kauffman WB, Fuselier T, He J, Wimley WC (2015) Mechanism matters: a taxonomy of cell
penetrating peptides. Trends Biochem Sci 40(12):749–764. https://doi.org/10.1016/j.
tibs.2015.10.004
Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ (2010) Changes in the composition of the human
fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.
J Clin Gastroenterol 44(5):354–360. https://doi.org/10.1097/MCG.0b013e3181c87e02
Kolb SJ, Kissel JT (2011) Spinal muscular atrophy: a timely review. Arch Neurol 68(8):979–984.
https://doi.org/10.1001/archneurol.2011.74
Kolb SJ, Kissel JT (2015) Spinal muscular atrophy. Neurol Clin 33(4):831–846. https://doi.
org/10.1016/j.ncl.2015.07.004
Kurreck J (2003) Antisense technologies. Improvement through novel chemical modifications. Eur
J Biochem 270(8):1628–1644. https://doi.org/10.1046/j.1432-1033.2003.03555.x
Langdon A, Crook N, Dantas G (2016) The effects of antibiotics on the microbiome throughout
development and alternative approaches for therapeutic modulation. Genome Med 8(1):39.
https://doi.org/10.1186/s13073-016-0294-z
Langel U (2019) Classes and applications of cell-penetrating peptides. In: CPP, cell-penetrating
peptides. Springer, Singapore, pp 61–63
Le CF, Fang CM, Sekaran SD (2017) Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother 61(4). https://doi.org/10.1128/AAC.02340-16
Lehman SM, Donlan RM (2015) Bacteriophage-mediated control of a two-species biofilm formed
by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary
A. Valsamatzi-Panagiotou et al.